bisoprolol has been researched along with Marfan Syndrome in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jondeau, G | 1 |
| Barthelet, M | 1 |
| Baumann, C | 1 |
| Bonnet, D | 1 |
| Chevallier, B | 1 |
| Collignon, P | 1 |
| Dulac, Y | 1 |
| Edouard, T | 1 |
| Faivre, L | 1 |
| Germain, D | 1 |
| Khau Van Kien, P | 1 |
| Lacombe, D | 1 |
| Ladouceur, M | 1 |
| Lemerrer, M | 1 |
| Leheup, B | 1 |
| Lupoglazoff, JM | 1 |
| Magnier, S | 1 |
| Muti, C | 1 |
| Plauchu, PH | 1 |
| Raffestin, B | 1 |
| Sassolas, F | 1 |
| Schleich, JM | 1 |
| Sidi, D | 1 |
| Themar-Noël, C | 1 |
| Varin, J | 1 |
| Wolf, JE | 1 |
1 other study available for bisoprolol and Marfan Syndrome
| Article | Year |
|---|---|
[Recommendations for the medical management of aortic complications of Marfan's syndrome].
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm; Aortic Dissection; Atenolol; Bisoprolol; Calcium Chann | 2006 |